MY118822A - Compounds for inhibition of gastric acid secretion - Google Patents

Compounds for inhibition of gastric acid secretion

Info

Publication number
MY118822A
MY118822A MYPI98000774A MYPI9800774A MY118822A MY 118822 A MY118822 A MY 118822A MY PI98000774 A MYPI98000774 A MY PI98000774A MY PI9800774 A MYPI9800774 A MY PI9800774A MY 118822 A MY118822 A MY 118822A
Authority
MY
Malaysia
Prior art keywords
gastric acid
acid secretion
inhibition
compounds
formula
Prior art date
Application number
MYPI98000774A
Other languages
English (en)
Inventor
Amin Kosrat
Dahlstrom Mikael
Nordberg Peter
Starke Ingemar
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MY118822A publication Critical patent/MY118822A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI98000774A 1997-02-25 1998-02-23 Compounds for inhibition of gastric acid secretion MY118822A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds

Publications (1)

Publication Number Publication Date
MY118822A true MY118822A (en) 2005-01-31

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI98000774A MY118822A (en) 1997-02-25 1998-02-23 Compounds for inhibition of gastric acid secretion

Country Status (32)

Country Link
US (1) US6265415B1 (enExample)
EP (1) EP0971920B1 (enExample)
JP (1) JP2001512477A (enExample)
KR (1) KR20000075622A (enExample)
CN (1) CN1100056C (enExample)
AR (1) AR011134A1 (enExample)
AT (1) ATE218569T1 (enExample)
AU (1) AU723389B2 (enExample)
BR (1) BR9807457A (enExample)
CA (1) CA2280008A1 (enExample)
CZ (1) CZ291681B6 (enExample)
DE (1) DE69805787T2 (enExample)
DK (1) DK0971920T3 (enExample)
EE (1) EE04016B1 (enExample)
ES (1) ES2178169T3 (enExample)
HU (1) HUP0000720A3 (enExample)
ID (1) ID22218A (enExample)
IL (1) IL131122A0 (enExample)
IS (1) IS1901B (enExample)
MY (1) MY118822A (enExample)
NO (1) NO313009B1 (enExample)
NZ (1) NZ336878A (enExample)
PL (1) PL190379B1 (enExample)
PT (1) PT971920E (enExample)
RU (1) RU2193036C2 (enExample)
SE (1) SE9700661D0 (enExample)
SK (1) SK283903B6 (enExample)
TR (1) TR199902060T2 (enExample)
TW (1) TW568907B (enExample)
UA (1) UA64741C2 (enExample)
WO (1) WO1998037080A1 (enExample)
ZA (1) ZA981134B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JPH10502365A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクタータンパク質およびワクチン
EP0909323B1 (en) * 1996-01-04 2007-02-28 Novartis Vaccines and Diagnostics, Inc. Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) * 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
WO2004026867A2 (en) 2002-09-19 2004-04-01 Schering Corporation Imidazopyridines as cyclin dependent kinase inhibitors
PT2476667E (pt) * 2003-02-26 2014-09-18 Sugen Inc Compostos de aminoheteroarilo como inibidores da proteína quinase
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US20060194782A1 (en) * 2003-09-18 2006-08-31 Altana Pharma Ag Pharmacologically active imidazo[4,5-c] pyridines
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
JP4977465B2 (ja) * 2004-07-28 2012-07-18 武田薬品工業株式会社 ピロロ［２，３−ｃ］ピリジン化合物、その製造方法および用途
ES2426920T3 (es) 2004-09-03 2013-10-25 Yuhan Corporation Derivados de pirrolo[3,2-B]piridina y procesos para su preparación
DK1784402T3 (da) 2004-09-03 2011-11-14 Yuhan Corp Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling
DK1784404T3 (da) 2004-09-03 2012-02-13 Yuhan Corp Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
JP2008536817A (ja) * 2005-03-24 2008-09-11 グラクソ グループ リミテッド 胃腸疾患の処置用医薬として有用なイミダゾ（１，２−ａ）ピリジン誘導体
PT1963302E (pt) 2005-12-05 2013-04-09 Pfizer Prod Inc Polimorfos de um inibidor de c-met/hgfr
DE602006018354D1 (de) 2005-12-05 2010-12-30 Pfizer Prod Inc Verfahren zur behandlung von abnormalem zellwachstum
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
IN2012DN04917A (enExample) * 2009-11-05 2015-09-25 Univ Notre Dame Du Lac
EP2716642B1 (en) 2011-05-30 2016-07-20 Astellas Pharma Inc. Imidazopyridine compound
EP2927231B1 (en) * 2012-11-30 2017-09-20 Astellas Pharma Inc. Imidazopyridine compounds
CN120117960A (zh) * 2025-05-12 2025-06-10 天津全和诚科技有限责任公司 一种杂质化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
CA2280008A1 (en) 1998-08-27
CZ301499A3 (cs) 2000-02-16
RU2193036C2 (ru) 2002-11-20
DK0971920T3 (da) 2002-09-16
CN1100056C (zh) 2003-01-29
PL335485A1 (en) 2000-04-25
KR20000075622A (ko) 2000-12-26
IS5148A (is) 1999-08-05
IS1901B (is) 2003-11-20
CZ291681B6 (cs) 2003-04-16
EE9900367A (et) 2000-04-17
AR011134A1 (es) 2000-08-02
DE69805787T2 (de) 2003-01-02
ID22218A (id) 1999-09-16
WO1998037080A1 (en) 1998-08-27
SE9700661D0 (sv) 1997-02-25
IL131122A0 (en) 2001-01-28
UA64741C2 (uk) 2004-03-15
DE69805787D1 (de) 2002-07-11
ZA981134B (en) 1998-08-25
HUP0000720A2 (hu) 2000-10-28
ATE218569T1 (de) 2002-06-15
PT971920E (pt) 2002-11-29
SK109999A3 (en) 2000-01-18
ES2178169T3 (es) 2002-12-16
US6265415B1 (en) 2001-07-24
JP2001512477A (ja) 2001-08-21
BR9807457A (pt) 2000-04-25
CN1248257A (zh) 2000-03-22
NO994078D0 (no) 1999-08-24
AU6314798A (en) 1998-09-09
PL190379B1 (pl) 2005-12-30
TR199902060T2 (xx) 2000-02-21
SK283903B6 (sk) 2004-04-06
NO313009B1 (no) 2002-07-29
HK1024248A1 (en) 2000-10-05
NZ336878A (en) 2001-05-25
EP0971920B1 (en) 2002-06-05
MX9907650A (es) 2002-12-13
AU723389B2 (en) 2000-08-24
EP0971920A1 (en) 2000-01-19
TW568907B (en) 2004-01-01
NO994078L (no) 1999-08-24
HUP0000720A3 (en) 2001-01-29
EE04016B1 (et) 2003-04-15

Similar Documents

Publication Publication Date Title
TW515798B (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
SE9700661D0 (sv) New compounds
MY121389A (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
MY119012A (en) New compounds
NZ510180A (en) Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors
SE9401197D0 (sv) Active compounds
WO2000011000A3 (en) New compounds
MY121387A (en) Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
SE0102808D0 (sv) New compounds
PL357811A1 (en) Alkylated imidazopyridine derivatives
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
IL109685A0 (en) Gastric acid secretion inhibiting compounds
JPS6471876A (en) Pyrrolo(1,2-a)imidazole, imidazo(1,2-a)pyridine derivative and use as 5-lipoxygenase inhibitor
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
TW200503702A (en) Novel imidazopyridine compound ii with therapeutic effect